Immature monocyte derived dendritic cells gene expression profile in response to virus-like particles stimulation

Eleonora Aricò, Ena Wang, Maria Lina Tornesello, Maria Tagliamonte, George K. Lewis, Francesco M. Marincola, Franco M. Buonaguro, Luigi Buonaguro

Research output: Contribution to journalArticle

36 Citations (Scopus)

Abstract

We have recently developed a candidate HIV-1 vaccine model based on HIV-1 Pr55gag Virus-Like Particles (HIV-VLPs), produced in a baculovirus expression system and presenting a gp120 molecule from an Ugandan HIV-1 isolate of the clade A (HIV-VLPAS). The HIV-VLPAS induce in Balb/c mice systemic and mucosal neutralizing Antibodies as well as cytotoxic T lymphocytes, by intra-peritoneal as well as intra-nasal administration. Moreover, we have recently shown that the baculovirus-expressed HIV-VLPs induce maturation and activation of monocyte-derived dendritic cells (MDDCs) which, in turn, produce Th1-and Th2-specific cytokines and stimulate in vitro a primary and secondary response in autologous CD4+ T cells. In the present manuscript, the effects of the baculovirus-expressed HIV-VLPAS on the genomic transcriptional profile of MDDCs obtained from normal healthy donors have been evaluated. The HIV-VLPA stimulation, compared to both PBS and LPS treatment, modulate the expression of genes involved in the morphological and functional changes characterizing the MDDCs activation and maturation. The results of gene profiling analysis here presented are highly informative on the global pattern of gene expression alteration underlying the activation of MDDCs by HIV-VLPAs at the early stages of the immune response and may be extremely helpful for the identification of exclusive activation markers.

Original languageEnglish
Article number45
JournalJournal of Translational Medicine
Volume3
DOIs
Publication statusPublished - 29 Dec 2005
Externally publishedYes

Fingerprint

Viruses
Transcriptome
Gene expression
Virion
Dendritic Cells
Monocytes
Chemical activation
HIV
HIV-1
Baculoviridae
T-cells
Genes
Gene Expression
Intranasal Administration
Neutralizing Antibodies
AIDS Vaccines
Manuscripts
Cytotoxic T-Lymphocytes
Vaccines
Cytokines

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)
  • Medicine(all)

Cite this

Immature monocyte derived dendritic cells gene expression profile in response to virus-like particles stimulation. / Aricò, Eleonora; Wang, Ena; Tornesello, Maria Lina; Tagliamonte, Maria; Lewis, George K.; Marincola, Francesco M.; Buonaguro, Franco M.; Buonaguro, Luigi.

In: Journal of Translational Medicine, Vol. 3, 45, 29.12.2005.

Research output: Contribution to journalArticle

Aricò, Eleonora ; Wang, Ena ; Tornesello, Maria Lina ; Tagliamonte, Maria ; Lewis, George K. ; Marincola, Francesco M. ; Buonaguro, Franco M. ; Buonaguro, Luigi. / Immature monocyte derived dendritic cells gene expression profile in response to virus-like particles stimulation. In: Journal of Translational Medicine. 2005 ; Vol. 3.
@article{21ae0b591e87421b938c1090c2d13f0a,
title = "Immature monocyte derived dendritic cells gene expression profile in response to virus-like particles stimulation",
abstract = "We have recently developed a candidate HIV-1 vaccine model based on HIV-1 Pr55gag Virus-Like Particles (HIV-VLPs), produced in a baculovirus expression system and presenting a gp120 molecule from an Ugandan HIV-1 isolate of the clade A (HIV-VLPAS). The HIV-VLPAS induce in Balb/c mice systemic and mucosal neutralizing Antibodies as well as cytotoxic T lymphocytes, by intra-peritoneal as well as intra-nasal administration. Moreover, we have recently shown that the baculovirus-expressed HIV-VLPs induce maturation and activation of monocyte-derived dendritic cells (MDDCs) which, in turn, produce Th1-and Th2-specific cytokines and stimulate in vitro a primary and secondary response in autologous CD4+ T cells. In the present manuscript, the effects of the baculovirus-expressed HIV-VLPAS on the genomic transcriptional profile of MDDCs obtained from normal healthy donors have been evaluated. The HIV-VLPA stimulation, compared to both PBS and LPS treatment, modulate the expression of genes involved in the morphological and functional changes characterizing the MDDCs activation and maturation. The results of gene profiling analysis here presented are highly informative on the global pattern of gene expression alteration underlying the activation of MDDCs by HIV-VLPAs at the early stages of the immune response and may be extremely helpful for the identification of exclusive activation markers.",
author = "Eleonora Aric{\`o} and Ena Wang and Tornesello, {Maria Lina} and Maria Tagliamonte and Lewis, {George K.} and Marincola, {Francesco M.} and Buonaguro, {Franco M.} and Luigi Buonaguro",
year = "2005",
month = "12",
day = "29",
doi = "10.1186/1479-5876-3-45",
language = "English",
volume = "3",
journal = "Journal of Translational Medicine",
issn = "1479-5876",
publisher = "BioMed Central",

}

TY - JOUR

T1 - Immature monocyte derived dendritic cells gene expression profile in response to virus-like particles stimulation

AU - Aricò, Eleonora

AU - Wang, Ena

AU - Tornesello, Maria Lina

AU - Tagliamonte, Maria

AU - Lewis, George K.

AU - Marincola, Francesco M.

AU - Buonaguro, Franco M.

AU - Buonaguro, Luigi

PY - 2005/12/29

Y1 - 2005/12/29

N2 - We have recently developed a candidate HIV-1 vaccine model based on HIV-1 Pr55gag Virus-Like Particles (HIV-VLPs), produced in a baculovirus expression system and presenting a gp120 molecule from an Ugandan HIV-1 isolate of the clade A (HIV-VLPAS). The HIV-VLPAS induce in Balb/c mice systemic and mucosal neutralizing Antibodies as well as cytotoxic T lymphocytes, by intra-peritoneal as well as intra-nasal administration. Moreover, we have recently shown that the baculovirus-expressed HIV-VLPs induce maturation and activation of monocyte-derived dendritic cells (MDDCs) which, in turn, produce Th1-and Th2-specific cytokines and stimulate in vitro a primary and secondary response in autologous CD4+ T cells. In the present manuscript, the effects of the baculovirus-expressed HIV-VLPAS on the genomic transcriptional profile of MDDCs obtained from normal healthy donors have been evaluated. The HIV-VLPA stimulation, compared to both PBS and LPS treatment, modulate the expression of genes involved in the morphological and functional changes characterizing the MDDCs activation and maturation. The results of gene profiling analysis here presented are highly informative on the global pattern of gene expression alteration underlying the activation of MDDCs by HIV-VLPAs at the early stages of the immune response and may be extremely helpful for the identification of exclusive activation markers.

AB - We have recently developed a candidate HIV-1 vaccine model based on HIV-1 Pr55gag Virus-Like Particles (HIV-VLPs), produced in a baculovirus expression system and presenting a gp120 molecule from an Ugandan HIV-1 isolate of the clade A (HIV-VLPAS). The HIV-VLPAS induce in Balb/c mice systemic and mucosal neutralizing Antibodies as well as cytotoxic T lymphocytes, by intra-peritoneal as well as intra-nasal administration. Moreover, we have recently shown that the baculovirus-expressed HIV-VLPs induce maturation and activation of monocyte-derived dendritic cells (MDDCs) which, in turn, produce Th1-and Th2-specific cytokines and stimulate in vitro a primary and secondary response in autologous CD4+ T cells. In the present manuscript, the effects of the baculovirus-expressed HIV-VLPAS on the genomic transcriptional profile of MDDCs obtained from normal healthy donors have been evaluated. The HIV-VLPA stimulation, compared to both PBS and LPS treatment, modulate the expression of genes involved in the morphological and functional changes characterizing the MDDCs activation and maturation. The results of gene profiling analysis here presented are highly informative on the global pattern of gene expression alteration underlying the activation of MDDCs by HIV-VLPAs at the early stages of the immune response and may be extremely helpful for the identification of exclusive activation markers.

UR - http://www.scopus.com/inward/record.url?scp=30544433937&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=30544433937&partnerID=8YFLogxK

U2 - 10.1186/1479-5876-3-45

DO - 10.1186/1479-5876-3-45

M3 - Article

VL - 3

JO - Journal of Translational Medicine

JF - Journal of Translational Medicine

SN - 1479-5876

M1 - 45

ER -